# Gene Therapy in Treating Patients With Cancer of The Liver

> **NCT00003147** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 30 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **BIOLOGICAL:** Ad5CMV-p53 gene

## Key facts

- **NCT ID:** NCT00003147
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-02
- **Primary completion:** 2003-06
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Administratively complete.
- **Last updated:** 2013-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003147, "Gene Therapy in Treating Patients With Cancer of The Liver". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*